Status:
UNKNOWN
"Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network"
Lead Sponsor:
University Hospital Muenster
Collaborating Sponsors:
privates Institut für angewandte Versorgungsforschung GmbH
AOK PLUS
Conditions:
Parkinson Disease
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of an online platform that allows neurologists and therapists to exchange therapy recommendations, communicate assessments and plan physical thera...
Detailed Description
The aim of this study is to enroll 185 patients in the intervention group and 185 patients in the control group. Patients in the intervention group come from the same region (Münsterland), the control...
Eligibility Criteria
Inclusion
- Inclusion Criteria (Intervention Group):
- Idiopathic Parkinson's Disease with pharmacological treatment
- 30 years old or older
- place of residence: Münsterland, Tecklenburger Land, Kreis and Stadt Osnabrück
- sufficient knowledge of the German language, should be able to understand the consent form
- Exclusion Criteria:
- severe cognitive deficits
- Atypical Parkinsonian Disorders
- participation in other studies
Exclusion
Key Trial Info
Start Date :
November 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
370 Patients enrolled
Trial Details
Trial ID
NCT05251298
Start Date
November 28 2021
End Date
October 1 2024
Last Update
April 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Münster, Klinik für Neurologie
Münster, North Rhine-Westphalia, Germany, 48149